Active	Status	Sponsor type	Region	Phase	Filter
30 Active 27 Inactive 57 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

17 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Valipour, Arschang
BLOC, NCT05911009 / 2022-003452-14: To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID	Completed	2	119	Europe	BC 007 or matching placebo	Berlin Cures GmbH, Berlin Cures GmbH	Long Covid	06/24	09/24
NCT06035120: An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema	Recruiting	N/A	200	Europe, US, RoW	AeriSeal System	Pulmonx Corporation	Emphysema, Pulmonary, Emphysema or COPD	06/27	03/28
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis	Active, not recruiting	N/A	270	Europe, US	RheOx Bronchial Rheoplasty, Sham Procedure	Gala Therapeutics, Inc.	Chronic Bronchitis	05/24	10/25
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD	Active, not recruiting	N/A	464	Europe, US	Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care	Nuvaira, Inc.	COPD	10/24	09/28
NCT04182841: RheOx Registry Study in Europe	Recruiting	N/A	100	Europe	RheOx	Gala Therapeutics, Inc.	Chronic Bronchitis, COPD	12/24	12/25
BREATHE-2, NCT05949645: Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema	Active, not recruiting	N/A	30	Europe	Apreo Implant Group	Apreo Health, Inc.	Emphysema or COPD	10/24	06/26
NCT03318406: Post-Market BTVA Registry	Recruiting	N/A	300	Europe	Bronchoscopic Thermal Vapor Ablation, BTVA, InterVapor	Uptake Medical Technology, Inc.	Emphysema or COPD	12/27	12/30
VAPORIZED, NCT03514329: Vapor Ablation for Localized Cancer Lesions	Not yet recruiting	N/A	10	Europe	Bronchoscopic Thermal Vapor Ablation, BTVA-C	Uptake Medical Technology, Inc.	Non Small Cell Lung Cancer, Metastatic Lung Cancer, Lung Cancer	03/28	06/28
Slebos, Dirk-Jan
CONVERT, NCT04559464: Fissure Closure With the AeriSeal System for ing Collateral Ventilation Status	Completed	N/A	102	Europe, RoW	AeriSeal, Zephyr Valves, Bronchoscopic Lung Volume Reduction (BLVR), Zephyr System	Pulmonx Corporation	Emphysema, COPD, Severe Emphysema	10/23	10/24
NCT06035120: An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema	Recruiting	N/A	200	Europe, US, RoW	AeriSeal System	Pulmonx Corporation	Emphysema, Pulmonary, Emphysema or COPD	06/27	03/28
IAB-1, NCT05087641: A Multicenter, Prospective Trial of the IAB in Adults Suffering From COPD/Emphysema	Active, not recruiting	N/A	20	Europe, RoW	IAB System	Pulmair Medical, Inc.	Emphysema, Pulmonary Disease, Chronic Obstructive	04/24	01/27
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis	Active, not recruiting	N/A	270	Europe, US	RheOx Bronchial Rheoplasty, Sham Procedure	Gala Therapeutics, Inc.	Chronic Bronchitis	05/24	10/25
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD	Active, not recruiting	N/A	464	Europe, US	Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care	Nuvaira, Inc.	COPD	10/24	09/28
BREATHE-2, NCT05949645: Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema	Active, not recruiting	N/A	30	Europe	Apreo Implant Group	Apreo Health, Inc.	Emphysema or COPD	10/24	06/26
Hartman, Jorine
CONVERT, NCT04559464: Fissure Closure With the AeriSeal System for ing Collateral Ventilation Status	Completed	N/A	102	Europe, RoW	AeriSeal, Zephyr Valves, Bronchoscopic Lung Volume Reduction (BLVR), Zephyr System	Pulmonx Corporation	Emphysema, COPD, Severe Emphysema	10/23	10/24
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis	Active, not recruiting	N/A	270	Europe, US	RheOx Bronchial Rheoplasty, Sham Procedure	Gala Therapeutics, Inc.	Chronic Bronchitis	05/24	10/25
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD	Active, not recruiting	N/A	464	Europe, US	Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care	Nuvaira, Inc.	COPD	10/24	09/28

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Valipour, Arschang
BLOC, NCT05911009 / 2022-003452-14: To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID	Completed	2	119	Europe	BC 007 or matching placebo	Berlin Cures GmbH, Berlin Cures GmbH	Long Covid	06/24	09/24
NCT06035120: An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema	Recruiting	N/A	200	Europe, US, RoW	AeriSeal System	Pulmonx Corporation	Emphysema, Pulmonary, Emphysema or COPD	06/27	03/28
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis	Active, not recruiting	N/A	270	Europe, US	RheOx Bronchial Rheoplasty, Sham Procedure	Gala Therapeutics, Inc.	Chronic Bronchitis	05/24	10/25
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD	Active, not recruiting	N/A	464	Europe, US	Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care	Nuvaira, Inc.	COPD	10/24	09/28
NCT04182841: RheOx Registry Study in Europe	Recruiting	N/A	100	Europe	RheOx	Gala Therapeutics, Inc.	Chronic Bronchitis, COPD	12/24	12/25
BREATHE-2, NCT05949645: Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema	Active, not recruiting	N/A	30	Europe	Apreo Implant Group	Apreo Health, Inc.	Emphysema or COPD	10/24	06/26
NCT03318406: Post-Market BTVA Registry	Recruiting	N/A	300	Europe	Bronchoscopic Thermal Vapor Ablation, BTVA, InterVapor	Uptake Medical Technology, Inc.	Emphysema or COPD	12/27	12/30
VAPORIZED, NCT03514329: Vapor Ablation for Localized Cancer Lesions	Not yet recruiting	N/A	10	Europe	Bronchoscopic Thermal Vapor Ablation, BTVA-C	Uptake Medical Technology, Inc.	Non Small Cell Lung Cancer, Metastatic Lung Cancer, Lung Cancer	03/28	06/28
Slebos, Dirk-Jan
CONVERT, NCT04559464: Fissure Closure With the AeriSeal System for ing Collateral Ventilation Status	Completed	N/A	102	Europe, RoW	AeriSeal, Zephyr Valves, Bronchoscopic Lung Volume Reduction (BLVR), Zephyr System	Pulmonx Corporation	Emphysema, COPD, Severe Emphysema	10/23	10/24
NCT06035120: An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema	Recruiting	N/A	200	Europe, US, RoW	AeriSeal System	Pulmonx Corporation	Emphysema, Pulmonary, Emphysema or COPD	06/27	03/28
IAB-1, NCT05087641: A Multicenter, Prospective Trial of the IAB in Adults Suffering From COPD/Emphysema	Active, not recruiting	N/A	20	Europe, RoW	IAB System	Pulmair Medical, Inc.	Emphysema, Pulmonary Disease, Chronic Obstructive	04/24	01/27
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis	Active, not recruiting	N/A	270	Europe, US	RheOx Bronchial Rheoplasty, Sham Procedure	Gala Therapeutics, Inc.	Chronic Bronchitis	05/24	10/25
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD	Active, not recruiting	N/A	464	Europe, US	Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care	Nuvaira, Inc.	COPD	10/24	09/28
BREATHE-2, NCT05949645: Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema	Active, not recruiting	N/A	30	Europe	Apreo Implant Group	Apreo Health, Inc.	Emphysema or COPD	10/24	06/26
Hartman, Jorine
CONVERT, NCT04559464: Fissure Closure With the AeriSeal System for ing Collateral Ventilation Status	Completed	N/A	102	Europe, RoW	AeriSeal, Zephyr Valves, Bronchoscopic Lung Volume Reduction (BLVR), Zephyr System	Pulmonx Corporation	Emphysema, COPD, Severe Emphysema	10/23	10/24
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis	Active, not recruiting	N/A	270	Europe, US	RheOx Bronchial Rheoplasty, Sham Procedure	Gala Therapeutics, Inc.	Chronic Bronchitis	05/24	10/25
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD	Active, not recruiting	N/A	464	Europe, US	Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care	Nuvaira, Inc.	COPD	10/24	09/28